Copyright
©The Author(s) 2025.
World J Gastroenterol. Oct 21, 2025; 31(39): 110986
Published online Oct 21, 2025. doi: 10.3748/wjg.v31.i39.110986
Published online Oct 21, 2025. doi: 10.3748/wjg.v31.i39.110986
Drug | Type | Approved use | Target pathway(s)/molecule(s) | Effects | Ref. |
Doxycicline | Antibiotic | Bacterial infection | MAPK, Wnt | Inhibit proliferation, colony formation, and spheroid growth | Magnelli et al[30]; Pandian et al[31] |
Lovastatin | Statin | Lower cholesterol | MAPK | Inhibit growth, increase sensitivity of anti-HER2 therapy, radioprotective effects in healthy tissues | Gao et al[32]; Zhang et al[33]; Du et al[34]; Rao et al[35] |
Silymarin | Natural product | Epilepsy and hepato-protection | MAPK | Inhibit growth and proliferation in vivo and in vitro | Koltai and Fliegel[36]; Kim et al[37] |
Tegaserod | 5-HTR4 receptor agonist | Irritable bowel syndrome | MAPK | Inhibit growth in vivo and in vitro | Chen et al[38]; Wang et al[39] |
Trametinib | MEK inhibitor | Melanoma | MAPK | Suppress tumor development and liver metastasis in mouse organoids | Yamasaki et al[40]; Wang et al[41] |
ATRA | Ligand for retinoic acid and retinoic X receptor | Promyelocytic leukemia | PI3K, Wnt | Suppress proliferation in vivo and in vitro | Bouriez et al[43]; Zhang et al[44]; Jin et al[45] |
Danusertib/alisertib | Aurora kinase inhibitors | Not approved (phase II for prostate cancer and phase III for lymphoma, respectively) | MAPK | Inhibit proliferation, induce cell cycle arrest, and promote apoptosis and autophagy | Yuan et al[46]; Yuan et al[47]; Novais et al[48] |
Deferasirox | Iron chelator | Iron overload disease | mTOR | Induce apoptosis | Choi et al[49] |
Dronedarone | Antiarrhythmic | Auricular fibrillation | PI3K | Suppress cell proliferation and colony formation | Lu et al[50]; CIMA[113] |
Metformin | Biguanide | Type 2 diabetes | PI3K | Induce apoptosis in vitro | Lu et al[51]; Lan et al[52]; Hu et al[53] |
Mycophenolic acid | IMPDH inhibitor | Organ transplant, lupus eritrematosus | PI3K | Inhibit proliferation | Hsieh et al[54]; Dun et al[55] |
Naftopidil | Α-1-adrenoceptor blocker | Benign prostate hyperplasia | PI3K | Induce apoptosis | Nakamura et al[56]; Kaku et al[57]; Florent et al[58] |
Rapamycin | mTOR inhibitor | Organ transplant | mTOR, HIF-1α | Reduce cell proliferation and invasiveness | Chen et al[59]; Morgos et al[60]; Liu et al[61]; CIMA[113] |
Sertraline | Antidepressant (SSRI) | Depression in cancer patients | PI3K, HIF-1α | Resensitize drug resistant GC | Mu et al[62]; Sánchez-Castillo et al[63]; Sun et al[64]; Wang et al[65] |
Vortioxetine | Antidepressant | Depression | PI3K, JAK2/STAT3 | Inhibit cell proliferation, migration, and invasion and induce apoptosis and autophagy | Chen et al[38]; Lv et al[66]; Li et al[67] |
Thioridazine | Antipsychotic | Schizophrenia | PI3K, Wnt | Reduce cell viability, induce apoptosis, and enhance anti-HER2 therapy | Yang et al[70] |
Tigecycline | Antibiotic | Complicated infections | PI3K | Induce autophagy and inhibit cell proliferation | Dong et al[71]; Tang et al[72] |
Valproic acid | HDAC1/2 inhibitor | Bipolar disorder, epilepsy | PI3K | Induce apoptosis | Zhang et al[33]; Fushida et al[73]; Sun et al[74] |
Econazole | Antifungal | Skin infections | p53, PI3K | Caspase-dependent apoptosis (p53 activation); inhibit metastasis (MMP2/9) | Choi et al[75] |
Bazedoxifene | Estrogen receptor modulator | Postmenopausal osteoporosis | JAK2/STAT3 | Reduce tumor burden | Thilakasiri et al[76]; Wu et al[77] |
Fedratinib | JAK2 inhibitor | Myelofibrosis | JAK2/STAT3 | Inhibit cell proliferation | Wang et al[41]; Passamonti et al[78]; Miyazaki et al[79]; Mao et al[80] |
Disulfiram | Acetaldehyde dehydrogenase inhibitor | Alcohol abuse | Wnt, NF-κB, MAPK | Inhibit proliferation and induce apoptosis | Zhang et al[86]; Liu et al[87] |
Propofol | Sedative-hypnotic | Anesthesia | Wnt, JAK2/STAT3 | Inhibit cell growth, invasion, and migration | Zhan et al[88]; Chen et al[89] |
Tipifarnib | Farnesyltransferase inhibitor | Not approved (phase II for HNSCC) | mTOR, HIF-1α | Inhibit proliferation and migration | Egawa et al[83]; Zhou et al[84] |
Simvastatin | Statin | Lower cholesterol | Wnt, Hippo | Inhibit proliferation and metastasis and reduce radiotoxicity of healthy tissues | Rao et al[35]; Liu et al[90] |
Bortezomib | Proteasome inhibitor | Multiple myeloma | NF-κB | Inhibit growth and induce apoptosis | Guo et al[91]; Nakata et al[92]; Ocean et al[93]; Bui et al[94] |
Propranolol | β-AR receptor blocker | Cardiovascular diseases, postmenopausal osteoporosis | NF-κB | Increase sensitivity to chemotherapy, cell cycle arrest, apoptosis, and inhibit tumor growth in xenograph models | Liao et al[95]; Koh et al[96] |
Resveratrol | Natural product | Metabolic and cardiovascular diseases | NF-κB | Decrease cell viability | Trautmann et al[97]; Rojo et al[98] |
Verteporfin | Benzoporphyrin | Photodinamic therapy | Hippo | Inhibit cell proliferation | Giraud et al[101] |
Abacavir | Nucleoside reverse transcriptase inhibitor | HIV infection | TERT | Insufficiently suppress cell proliferation and activate tumorigenic pathways | Panneerpandian et al[102] |
Candesartan | Angiotensin II type I receptor blocker | Hypertension, heart failure, diabetic neuropathy | TGF-β1 | Suppress tumor cell proliferation and stromal fibrosis in xenograph models | Araújo et al[29]; Okazaki et al[103] |
Telmisartan | Angiotensin II type I receptor blocker | Hypertension, heart failure, diabetic neuropathy | EGFR | Inhibit proliferation | Araújo et al[29]; Fujita et al[104] |
Fluoxetine | Antidepressant | Depression in cancer patients | Death receptor pathway | Induce apoptosis | Araújo et al[29]; Po et al[105] |
Itraconazole | Antifungal | Fungal infections | Hedgehog | Inhibit proliferation and increase apoptosis | Hu et al[106] |
Levobupivacaine | Local anesthetic | Anesthesia | Ferroptosis | Inhibit growth in vitro and in vivo and induce ferroptosis | Mao et al[107] |
Paroxetine | Antidepressant (SSRI) | Depression | DNA repair proteins | Induce apoptosis and inhibit cell viability | Liu et al[110]; Kowalska et al[111] |
Risperidone | Antipsychotic | Schizophrenia | Unknown (proposed: Histone deacethylation, dopamine receptor and cholesterol homeostasis) | Induce apoptosis and inhibit growth | Chen et al[112] |
- Citation: Valero-Almingol A, Montori S, Felípez N, Santamaría E, Fernandez-Irigoyen J, Luzko I, Cuestas AA, Pardo C, Prat R, Moreira L, Albéniz E. Targetable pathways for drug repurposing in gastric cancer. World J Gastroenterol 2025; 31(39): 110986
- URL: https://www.wjgnet.com/1007-9327/full/v31/i39/110986.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i39.110986